Pacira Pharma (PCRX) Misses Q1 EPS by 7c

Go back to Pacira Pharma (PCRX) Misses Q1 EPS by 7c

Pacira BioSciences Reports First Quarter 2021 Financial Results and Business Update

May 4, 2021 8:00 AM EDT

-- EXPAREL average daily sales at 115% of the prior year first quarter---- Conference call today at 8:30 a.m. ET --

PARSIPPANY, N.J., May 04, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the first quarter of 2021.

First Quarter 2021 Financial Highlights

Total revenues of $119.0 millionGAAP... More